07.01.25 -- Exploring The Market For Closed-Loop Cell Therapy Production

To ensure the safety, efficacy, and stability of monoclonal antibody therapies, it is crucial to understand the factors driving aggregation and implement effective strategies to mitigate its impact.

Gain essential insights and practical guidance on outsourcing drug development and manufacturing, helping you make informed decisions and accelerate the success of your therapeutic initiatives.

Technical transfers are one of the most critical, yet challenging steps in drug development; therefore, an effective strategy is essential to accelerate the translation of projects from bench to market.

For complex projects involving oral solid dosage (OSD) and sterile drug products, selecting the ideal CDMO can play a pivotal role in determining the success of a drug candidate.

Discover key factors that drive a seamless and efficient technology transfer. Learn how a culture of technical expertise, customer focus, and operational flexibility is crucial to CDMO success.